| Application no. and date | 01926498.5 (espacenet) (Federated) (European Patent Register), 20010330 | | Patent/reg. no. and date | DK/EP 1267945, 20111005 | | Publication date | 20030102 | | Priority no. and date | US 193497 P, 20000331 | | EP pub. no. and date |
EP 1267945 20030102 | | Effective date | | | Applicant/owner | Novarx, 6828 Nancy Ridge Drive, Suite 100
San Diego CA 92121-2635, US | | Applicant ref. no. | P48910DK01 | | Inventor | FAKHRAI, Habib, 8886 Caminito Primavera
La Jolla, CA 92037, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 35/42 (2006.01) , A61K 48/00 (2006.01) , A61P 35/00 (2006.01) , C12N 5/10 (2006.01) | | Title | Genetisk modificerede celler der udtrykker en TGF-beta-inhibitor, hvor cellerne er lungecancerceller | | Int. application no. | US2001010339 | | Int. publication no. | WO2001074404 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
